研究業績
英文論文 2015年度
- Kobayashi, A.，Takahashi, M.，Imai, H.，Akiyama, S.，Sugiyama, S.，Komine, K.，Saijo, K.，Takahashi, M.，Takahashi, S.，Shirota, H.，Sato, N.，Fujishima, F.，Shuin, T.，Shimodaira, H.，Ishioka, C.: Attainment of a Long-term Favorable Outcome by Sunitinib Treatment for Pancreatic Neuroendocrine Tumor and Renal Cell Carcinoma Associated with von Hippel-Lindau Disease. Intern Med 55. 629-34. Mar 18（2016）
- Ouchi, K.，Takahashi, S.，Yamada, Y.，Tsuji, S.，Tatsuno, K.，Takahashi, H.，Takahashi, N.，Takahashi, M.，Shimodaira, H.，Aburatani, H.，Ishioka, C.: DNA methylation status as a biomarker of anti-EGFR treatment for metastatic colorectal cancer. Cancer Sci 106. 1722–1729. Oct 1（2015）
- Komatsu, Y.，Ishioka, C.，Shimada, K.，Yamada, Y.，Gamoh, M.，Sato, A.，Yamaguchi, T.，Yuki, S.，Morita, S.，Takahashi, S.，Goto, R.，Kurihara, M.: Study protocol of the TRICOLORE trial: a randomized phase III study of oxaliplatin-based chemotherapy versus combination chemotherapy with S-1, irinotecan, and bevacizumab as first-line therapy for metastatic colorectal cancer. BMC Cancer 15. 626. Sep 12（2015）
- Yoshino, Y.，Ishioka, C.: Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells. Scientific Reports 5. 13249. Aug 21（2015）
- Yoshino, Y.，Suzuki, M.，Takahashi, H.，Ishioka, C.: Inhibition of invasion by glycogen synthase kinase-3 beta inhibitors through dysregulation of actin re-organisation via down-regulation of WAVE2. Biochem Biophys Res Commun 464. 275-80. Aug 14（2015）
- Watanabe, G.，Ishida, T.，Furuta, A.，Takahashi, S.，Watanabe, M.，Nakata, H.，Kato, S.，Ishioka, C.，Ohuchi, N.: Combined Immunohistochemistry of PLK1, p21, and p53 for Predicting TP53 Status: An Independent Prognostic Factor of Breast Cancer. Am J Surg Pathol 39. 1026-34. Aug（2015）
- Mori, T.，Sumii, M.，Fujishima, F.，Ueno, K.，Emi, M.，Nagasaki, M.，Ishioka, C.，Chiba, N.: Somatic alteration and depleted nuclear expression of BAP1 in human esophageal squamous cell carcinoma. Cancer Sci 106. 1118-1129. Jun 17（2015）
- Inoue, M.，Takahashi, S.，Soeda, H.，Shimodaira, H.，Watanabe, M.，Miura, K.，Sasaki, I.，Kato, S.，Ishioka, C.: Gene-expression profiles correlate with the efficacy of anti-EGFR therapy and chemotherapy for colorectal cancer. Int J Clin Oncol 20. 1147-1155. May 20（2015）
- Shirota, H.，Tross, D.，Klinman, D.: CpG Oligonucleotides as Cancer Vaccine Adjuvants. Vaccines 3. 390-407. May 8（2015）
- Hiratsuka, M.，Yamashita, H.，Akai, F.，Hosono, H.，Hishinuma, E.，Hirasawa, N.，Mori, T.: Genetic polymorphisms of dihydropyrimidinase in a Japanese patient with capecitabine-induced toxicity. PLoS One 10. e0124818. Apr 29（2015）
- Ohkawa, S.，Okusaka, T.，Isayama, H.，Fukutomi, A.，Yamaguchi, K.，Ikeda, M.，Funakoshi, A.，Nagase, M.，Hamamoto, Y.，Nakamori, S.，Tsuchiya, Y.，Baba, H.，Ishii, H.，Omuro, Y.，Sho, M.，Matsumoto, S.，Yamada, N.，Yanagimoto, H.，Unno, M.，Ichikawa, Y.，Takahashi, S.，Watanabe, G.，Wakabayashi, G.，Egawa, N.，Tsuda, M.，Hosotani, R.，Hamada, C.，Hyodo, I.: Randomised phase II trial of S-1 plus oxaliplatin vs S-1 in patients with gemcitabine-refractory pancreatic cancer. Br J Cancer 112. 1428-34. Apr 28（2015）